Literature DB >> 1339048

Epidemiology of bronchioloalveolar carcinoma.

R T Falk1, L W Pickle, E T Fontham, S D Greenberg, H L Jacobs, P Correa, J F Fraumeni.   

Abstract

Descriptive features of bronchioloalveolar carcinoma (BAC) are presented using Surveillance, Epidemiology and End Results Program population-based incidence data from 1973 through 1987, along with risk factors from histologically confirmed cases of BAC identified in a hospital-based case-control study conducted in Louisiana between 1979 and 1982. Compared to the rising incidence of lung cancer overall, BAC rates have remained relatively constant, accounting for less than 3% of all lung cancer. BAC incidence rates were higher in males, yet it explained proportionately more of the total lung cancer incidence in females. In the case-control study, 21 of the 33 cases originally ascertained from hospital pathology records were histologically confirmed as BAC. Most cases smoked cigarettes, with a 4-fold risk for ever smoking. Risks tended to increase with smoking intensity (reaching 10-fold for more than 1.5 packs/day) and duration (reaching 5-fold for more than 45 years of smoking). Following 10 or more years of employment, there was a 4-fold risk associated with motor freight occupations, along with nonsignificant excesses among construction workers, petroleum manufacturers, and sugar cane farmers. Cases were more likely than controls to have had emphysema or to have had a close family member with lung cancer. Although based on small numbers, this study suggests that BAC shares many of the epidemiological characteristics of lung adenocarcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1339048

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

Review 1.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

2.  Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.

Authors:  Jon O Ebbert; Laveena Chhatwani; Marie Christine Aubry; Jason Wampfler; Shawn Stoddard; Fang Zhang; Guibin Qiao; Mariza de Andrade; Ping Yang
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

3.  Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS).

Authors:  Paige M Bracci; Jennette Sison; Helen Hansen; Kyle M Walsh; Charles P Quesenberry; Dan J Raz; Margaret Wrensch; John K Wiencke
Journal:  J Thorac Oncol       Date:  2012-09       Impact factor: 15.609

4.  Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.

Authors:  Sharon Milberger; Ronald M Davis; Clifford E Douglas; John K Beasley; David Burns; Thomas Houston; Donald Shopland
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

5.  Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA).

Authors:  Claire H Kim; Yuan-Chin Amy Lee; Rayjean J Hung; Paolo Boffetta; Dong Xie; Jason A Wampfler; Michele L Cote; Shen-Chih Chang; Donatella Ugolini; Monica Neri; Loic Le Marchand; Ann G Schwartz; Hal Morgenstern; David C Christiani; Ping Yang; Zuo-Feng Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-26       Impact factor: 4.254

6.  The clinical use of PET with (11)C-acetate.

Authors:  Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

Review 7.  Emerging approaches to advanced bronchioloalveolar carcinoma.

Authors:  Howard West
Journal:  Curr Treat Options Oncol       Date:  2006-01

8.  Tobacco smoking as a risk factor of bronchioloalveolar carcinoma of the lung: pooled analysis of seven case-control studies in the International Lung Cancer Consortium (ILCCO).

Authors:  Paolo Boffetta; Vijayvel Jayaprakash; Ping Yang; Kofi Asomaning; Joshua E Muscat; Ann G Schwartz; Zuo-Feng Zhang; Loic Le Marchand; Michele L Cote; Shawn M Stoddard; Hal Morgenstern; Rayjean J Hung; David C Christiani
Journal:  Cancer Causes Control       Date:  2010-11-12       Impact factor: 2.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.